首页> 外文期刊>International journal of laboratory hematology >D-dimer use for deep venous thrombosis exclusion in elderly patients: A comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units
【24h】

D-dimer use for deep venous thrombosis exclusion in elderly patients: A comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units

机译:D-二聚体用于老年患者深静脉血栓形成的排除:三种分析方法的比较值,该方法确定了以D-二聚体单位表示的测定结果的临界值

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: The use of adapted cut-off values in the elderly, combined with clinical probability (PTP), increases the proportion of patients in whom venous thromboembolism (VTE) can be safely excluded, compared with the conventional cut-off value of 500 μg/L fibrinogen equivalent units (FEU). We evaluated the clinical performance of three different approaches to establish cut-off values for a D-dimer assay whose results are expressed in D-dimer units (D-DU). Methods: HemosIL D-dimer HS assay (Instrumentation Laboratory) was performed in 279 consecutive outpatients with suspected deep venous thrombosis (DVT) and nonhigh PTP. Results: Considering patients >60 years, the number of negative D-dimer results increased using the modified (376 ng/mL if ≥60 years) and the age-adjusted cut-off (age years × 5 ng/mL if >50 years) compared to the conventional one (230 ng/mL for all patients; 54.6%, 58.2%, and 25.0%, respectively), with no false-negative results. The higher increase was observed in patients >80 years (43.9%, 56.1%, and 8.8%, respectively). Conclusion: For the HemosIL D-dimer HS, the use of specific cut-off values in older subjects with suspected DVT and nonhigh PTP increases the number of patients in whom DVT can be safely excluded.
机译:简介:与传统的500μg临界值相比,在老年人中使用调整后的临界值并结合临床可能性(PTP)可增加可以安全排除静脉血栓栓塞(VTE)的患者比例/ L纤维蛋白原当量单位(FEU)。我们评估了三种不同方法为D-二聚体测定建立临界值的临床性能,其结果以D-二聚体单位(D-DU)表示。方法:对279例疑似深静脉血栓形成(DVT)和非高PTP的连续门诊患者进行了HemosIL D-二聚体HS检测(仪器实验室)。结果:考虑到> 60岁的患者,使用改良版(≥60岁,则为376 ng / mL)和经过年龄调整的临界值(≥50岁,则为年龄×5 ng / mL),增加了D-二聚体阴性结果的数量)与传统方法(所有患者均为230 ng / mL;分别为54.6%,58.2%和25.0%)相比,没有假阴性结果。在> 80岁的患者中观察到更高的增加(分别为43.9%,56.1%和8.8%)。结论:对于HemosIL D-二聚体HS,在疑似DVT和PTP不高的老年受试者中使用特定的临界值会增加DVT可安全排除的患者人数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号